Philippe Mathurin
Mathurin, Philippe, 1962-....
VIAF ID: 214110014 (Personal)
Permalink: http://viaf.org/viaf/214110014
Preferred Forms
- 100 1 _ ‡a Mathurin, Philippe ‡d 1962-...
- 100 1 _ ‡a Mathurin, Philippe, ‡d 1962-....
- 100 0 _ ‡a Philippe Mathurin
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
[30] INVOLVEMENT OF NOD SIGNALLING IN HEPATOCYTE AND IMMUNE CELLS DURING HEPATITIS | |
Etude prospective de l'évolution lésionnelle hépatique (inflammation, ballonisation et fibrose) après chirurgie bariatrique des patients obèses morbides atteints de stéatopathie métabolique sévère et/ou de stéatohépatique | |
Évaluation des scores pronostiques de gravité en cas d’ACLF chez des patients cirrhotiques : étude prospective monocentrique | |
Evolution de la stéatose non alcoolique (NAFLD) chez des patients obèses traités chirurgicalement par anneau gastrique ou by-pass | |
Influence pronostique de l'hépatite virale B ou C chez les patients transplantés rénaux | |
Intérêt d'un traitement anti-viral combiné dans la prise en charge des patients atteints d'hépatite B chronique | |
Is alcoholic hepatitis an indication for transplantation? Current management and outcomes. | |
L'évolution de la stéatose sévère après chirurgie de l'obésité est liée à l'insulino-résistance | |
The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. | |
L'INFLAMMATION DANS LA MALADIE ALCOOLIQUE DU FOIE : ETUDES CHEZ L'ANIMAL, ESSAIS CHEZ L'HOMME | |
Long-term metabolic outcome and quality of life after laparoscopic adjustable gastric banding in obese patients with type 2 diabetes mellitus or impaired fasting glucose. | |
Long-term results of percutaneous management for anastomotic biliary stricture after orthotopic liver transplantation | |
Main drivers of outcome differ between short and long-term in severe alcoholic hepatitis: A prospective study | |
Maladie de Still de l’adulte et angiosarcome hépatique, une association fortuite ou un syndrome paranéoplasique : à propos d’un cas | |
Management of alcohol dependence in transplant candidates: we are far away from the objective line. | |
Mass spectrometric approach for screening modifications of total serum N-glycome in human diseases: application to cirrhosis. | |
[Membranous glomerulonephritis complicating hepatocellular carcinoma] | |
Mésaventure au paracétamol et exacerbation de la toxicité en cas de surdosage chez le buveur excessif : deux entités controversées | |
Mesenteric adenitis and portal vein thrombosis due to Fusobacterium nucleatum. | |
micro-Opioid receptor activation prevents acute hepatic inflammation and cell death | |
MISE AU POINT DE L'AMPLIFICATION GENIQUE COMPETITIVE POUR LA QUANTIFICATION DES TRANSCRITS DES APOLIPOPROTEINES AI ET AII CHEZ LE BUVEUR EXCESSIF | |
Mise en évidence de deux nouvelles fonctions du système endocannabinoïde dans la physiopathologie de la stéatose hépatique : propriétés stéatogènes du récepteur CB2 et profibrogéniques du récepteur CB1 | |
Le modèle de Lille : un nouvel outil pour prédire la survie à 6 mois des patients présentant une hépatite alcoolique sévère traités par corticoïdes | |
Modélisation de la morbi-mortalité du carcinome hépatocellulaire en France par stade de gravité : évaluation de différentes stratégies en fonction du dépistage et des ressources thérapeutiques | |
Modélisation de la stéatose hépatique (NAFLD) et de ses facteurs de risque par apprentissage sur des données de santé | |
Modelling of hepatic steatosis (NAFLD) and its risk factors by learning from health data. | |
Multicenter prospective validation of the Baveno IV and Baveno II/III criteria in cirrhosis patients with variceal bleeding | |
Mycophenolate mofetil monotherapy for severe side effects of calcineurin inhibitors following liver transplantation. | |
The negative impact of HBV/HCV coinfection on cirrhosis and its consequences | |
Neutrophil migration during liver injury is under nucleotide-binding oligomerization domain 1 control | |
NOD2: a potential target for regulating liver injury | |
Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir). | |
[Nuclear receptor PPAR and hepatology: pathophysiological and therapeutical aspects]. | |
Optimisation du traitement de l'hépatite alcoolique sévère et identification d'une nouvelle cible thérapeutique : le récepteur CB2 des cannabinoïdes | |
[Overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis] | |
Partial graft recovery following eradication of hepatitis E virus infection after successful islet allograft transplantation | |
Peroxisome proliferator-activated receptors in HBV-related infection | |
Perspectives on Treatment for Nonalcoholic Steatohepatitis | |
Phase II trial of docetaxel therapy in patients with advanced hepatocellular carcinoma | |
Polymorphonuclear neutrophils are a source of hepatocyte growth factor in patients with severe alcoholic hepatitis | |
Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial. | |
Prevalence of Cholelithiasis According to Alcoholic Liver Disease: A Possible Role of Apolipoproteins AI and AII | |
Prevalence of renal abnormalities in chronic HBV infection: the HARPE study. | |
Primary sarcoma of the liver and transplantation: a case study and literature review | |
Prise en charge chirurgicale de l'obèse et de l'obèse morbide : conséquences sur la stéatopathie métabolique et sur l'accès à la transplantation hépatique | |
Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis | |
Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis | |
Prospective analysis of aneurysm treatment in a series of 103 consecutive patients when endovascular embolization is considered the first option | |
Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease | |
Prothrombin index decrease: a useful and reliable marker of extensive fibrosis? | |
Raised plasma soluble Fas and Fas-ligand in alcoholic liver disease. | |
Randomised clinical trial: enteral nutrition does not improve the long-term outcome of alcoholic cirrhotic patients with jaundice | |
Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirin | |
Recalibrated MELD and hepatic encephalopathy are prognostic factors in cirrhotic patients with acute variceal bleeding. | |
Recurrent alcoholic cirrhosis in severe alcoholic relapse after liver transplantation: a frequent and serious complication | |
La réduction précoce de la charge virale peut prédire la réponse virologique des patients VHC génotypes non-2 non-3 non répondeurs retraités par bithérapie pegylée | |
Relationship between the hepatitis C viral load and the serum interferon concentration during the first week of peginterferon-alpha-2b-ribavirin combination therapy. | |
Relevance of the ISGLS definition of posthepatectomy liver failure in early prediction of poor outcome after liver resection: study on 680 hepatectomies. | |
Reply: To PMID 24677195 | |
Rôle des composés bactériens et de NOD 2 dans la cellule myofibroblastique hépatique | |
Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study | |
Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients | |
Safety and efficacy of sorafenib in hepatocellular carcinoma: the impact of the Child-Pugh score | |
Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for HBeAg-positive chronic hepatitis B. | |
Shortened treatment duration in treatment-naive genotype 1 HCV patients with rapid virological response: a meta-analysis | |
Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141). | |
Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia. | |
La stéatose hépatique métabolique vue par le médecin généraliste | |
Surgical clipping may lead to better results than coil embolization: results from a series of 101 consecutive unruptured intracranial aneurysms | |
Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis. | |
Therapeutic misadventure with acetaminophen in alcoholics | |
Tolérance et efficacité du système MARS® chez les patients présentant une hépatite alcoolique sévère non répondeurs aux corticoïdes : une étude pilote | |
A tool to predict progression of non-alcoholic fatty liver disease in severely obese patients | |
Towards a better understanding of alcohol-related liver disease and the factors influencing its progression : a modeling approach. | |
Transforming growth factor beta 1: in situ expression in the liver of patients with chronic hepatitis C treated with alpha interferon | |
Transvascular coil hooking procedure to retrieve an unraveled Guglielmi detachable coil: technical note. | |
Treatment of chronic hepatitis C by interferon for longer duration than six months | |
Trends in the management and burden of alcoholic liver disease. | |
Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities | |
Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites | |
The use of corticosteroids in severe alcohol hepatitis: we need to look beyond this controversy. | |
Usefulness of routine analysis of ascitic fluid at the time of therapeutic paracentesis in asymptomatic outpatients. Results of a multicenter prospective study. | |
Valeur pronostique du meld dans les hémorragies digestives du cirrhotique | |
Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity | |
Vers une meilleure compréhension de la maladie du foie liée à l'alcool et des facteurs influençant sa progression : approche de modélisation | |
Vialebex 200 mg/ml : albumine humaine : cas cliniques n° 3 | |
প্রত্যুত্তর |